Trials / Completed
CompletedNCT06567652
Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Universitair Ziekenhuis Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this retrospective observational study is to learn about the safety and efficacy of cryoballoon catheter ablation in 80 patients with persistent atrial fibrillation using the PolarX (Boston scientific) cryoablation technology. The main question it aims to answer is if it is safe and effective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | catheter ablation | All patients underwent pulmonary vein isolation (and eventually left atrial posterior wall isolation) with the POLARx™ cryoballoon system |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-08-31
- Completion
- 2022-09-01
- First posted
- 2024-08-23
- Last updated
- 2024-08-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT06567652. Inclusion in this directory is not an endorsement.